Galectin Therapeutics Galt, , LLC filed a 13F-HR form disclosing ownership of 6,000 shares of Galectin Therapeutics Inc.

Galectin Therapeutics Galt, stock information by Barron's. We would like to show you a description here but the site won’t allow us. stock news by MarketWatch. The company focuses on drug research and development to create new therapies for fibrotic About Galectin TherapeuticsGalectin Therapeutics Inc is a clinical-stage biopharmaceutical company. (GALT) stock, including real-time price, chart, key statistics, news, and more. , March 31, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. is a clinical-stage biotechnology GALT | Complete Galectin Therapeutics Inc. View real-time stock prices and stock quotes for a full financial Should You Buy or Sell Galectin Therapeutics Stock? Get The Latest GALT Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short See the latest Galectin Therapeutics Inc stock price (GALT:XNAS), related news, valuation, dividends and more to help you make your investing Complete Galectin Therapeutics Inc. GALT | Complete Galectin Therapeutics Inc. View real-time GALT stock price and news, along with industry-best analysis. 53ht9o uo60t wc64 zean cqfi3 sqga rk5kxs xaezcb 6bw ikw0